Q87F43 AF NFT

Alanine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidkhbzrgmndin3muucoofdgmmne4lhr2xvjq47wjwr35bautake2a/metadata.json
IPFS of structure file: 
bafybeidetm25txbxhwxwq3sm276xr2hh7fbui2ftaj24rqf7ffwaiphzta/AF-Q87F43-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x979E511aC79d68F7194b55462Bd9fE0E19DbE493
First NFT owner address (bech32): 
genesis1j709zxk8n450wx2t24rzhk07pcvaheynxre6kk
Current NFT ID #443530 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
443530
Accession (UniProt):
Q87F43
Name::
Alanine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Xylella fastidiosa (strain Temecula1 / ATCC 700964)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q87F43 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q87F43|SYA_XYLFT Alanine--tRNA ligase OS=Xylella fastidiosa (strain Temecula1 / ATCC 700964) OX=183190 GN=alaS PE=3 SV=1 MNIPTKFTTSKIRSDFLEFFKNKGHKIVPSAPLVPSNDPTLLFTNSGMVQFKDVFLGAEKRSEVRVADVQCCLRAGGKHNDLDSVGYTARHHTFFEMLGNWSFGDYFKKEAIMWAWELLTQVWELPPERLLVTVYHTDDESYALWRDMVGVPEDRIVRIGDNKGAPFASDNFWQMADTGPCGPCTEIFYDHGEHIPGGPPGSPGEDGDRFIEIWNLVFMQFDRQSDGTLVPLPTPCVDTGMGLERLAAILQHVHTNYEIDLFQTLILKAAELTAVADVQNKSLCVIADHSRACAFLIVDGVLPSNEGRGYVLRRIIRRALRHGWMLGVRQPFFNNMVPTLIAVMGDAYPKLQAAAESVMRTLLAEEERFAETLDVGMKIFNEVAAKVANGVIPGSDAFRLYDTYGFPVDLTADIARERGMRVDMAGFEAAMTQQRKTARAAGKFGRGVQLSAERAATLSPTVFLGYEQLQADDLRVVALLSDGGLTDSASVGDEVIVLTDRTPFYAESGGQVGDIGTLMASDGVRLEVTDTQKLMGQFHGHVARIVQGGVKVGDVLSGSVAVARRKMVALNHSATHLLHCALRSVFGTHVVQKGSLVAPDRLRFDFSHFEPISAAQMTLIERMVNDEVRANHLVMIEQMGMQAALDAGAMALFGEKYGEHVRVVTMGTSVELCGGTHITRTGDIGLFKIISECGVSSGVRRIEAVTGESALNHVLAEEHRLYEVAGLIGSNANNVVNHIRQLTDRQKTLERELEKLKGKLISGTITDLLSMAVNVADVKVVAARLDGLDGKALREALDRLKLQLSDAVIVLAGVTGGKVALVTAVNGPRAMGKVKADTLLSHVATQINGRGGGRVDFAQGGGEDGPSLRSALDGVATWVKQHLN